Cancer cells undergoing EMT processes implicate the loss of cell polarity and lead to the transformation of the mesenchymal phenotype, accompanied by regulation of E-cadherin and the upregulation of vimentin and/or N-cadherin. The gene discussed is CDH2; the disease is cancer.